Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Timothy Pollak

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Gastrointestinal and Liver Diseases : JGLD|April 3, 2010
How toxic is amiodarone to the liver?P Timothy Pollak
The Canadian Journal of Cardiology|July 30, 2013
Nondaily statin dosing: mechanisms of a potentially important approach to dealing with statin intoleranceP Timothy Pollak
The Canadian Journal of Cardiology|March 19, 2005
What is a doctor to do...with digoxin?P Timothy Pollak
The Canadian Journal of Cardiology|November 26, 2015
Herbal Cardiotoxicity: Can Mother Nature Hurt the Heart?P Timothy Pollak
The Canadian Journal of Cardiology|November 5, 2019
Asleep at the Switch? Are We Failing to Recognize Obstructive Sleep Apnea in Patients with Atrial Fibrillation and Heart Failure?P Timothy Pollak, Marcus Povitz
The Journal of Emergency Medicine|July 17, 2003
Delayed recovery associated with persistent serum concentrations after clozapine overdoseLyle Thomas, P Timothy Pollak
The Canadian Journal of Cardiology|June 2, 2019
Monitoring Direct Oral Anticoagulants: Longing for the Days When We Were in Control?P Timothy Pollak, L Brent Mitchell
The Canadian Journal of Cardiology|October 16, 2020
Anticoagulation Therapy for Patients With New-Onset Postoperative Atrial Fibrillation After Noncardiac Surgery: Must Do, May Do, or Don't Do?P Timothy Pollak, L Brent Mitchell
Clinical Pharmacology and Therapeutics|April 3, 2004
Use of population modeling to define rational monitoring of amiodarone hepatic effectsP Timothy Pollak, Steven L Shafer
The American Journal of Cardiology|March 5, 2003
Monitoring of hepatic function during amiodarone therapyP Timothy Pollak, Yong Dong You
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Gastrointestinal and Liver Diseases : JGLD|April 3, 2010
How toxic is amiodarone to the liver?P Timothy Pollak
The Canadian Journal of Cardiology|July 30, 2013
Nondaily statin dosing: mechanisms of a potentially important approach to dealing with statin intoleranceP Timothy Pollak
The Canadian Journal of Cardiology|March 19, 2005
What is a doctor to do...with digoxin?P Timothy Pollak
The Canadian Journal of Cardiology|November 26, 2015
Herbal Cardiotoxicity: Can Mother Nature Hurt the Heart?P Timothy Pollak
The Canadian Journal of Cardiology|November 5, 2019
Asleep at the Switch? Are We Failing to Recognize Obstructive Sleep Apnea in Patients with Atrial Fibrillation and Heart Failure?P Timothy Pollak, Marcus Povitz
The Journal of Emergency Medicine|July 17, 2003
Delayed recovery associated with persistent serum concentrations after clozapine overdoseLyle Thomas, P Timothy Pollak
The Canadian Journal of Cardiology|June 2, 2019
Monitoring Direct Oral Anticoagulants: Longing for the Days When We Were in Control?P Timothy Pollak, L Brent Mitchell
The Canadian Journal of Cardiology|October 16, 2020
Anticoagulation Therapy for Patients With New-Onset Postoperative Atrial Fibrillation After Noncardiac Surgery: Must Do, May Do, or Don't Do?P Timothy Pollak, L Brent Mitchell
Clinical Pharmacology and Therapeutics|April 3, 2004
Use of population modeling to define rational monitoring of amiodarone hepatic effectsP Timothy Pollak, Steven L Shafer
The American Journal of Cardiology|March 5, 2003
Monitoring of hepatic function during amiodarone therapyP Timothy Pollak, Yong Dong You
Pageof 3